MedTrace Logo

High Deductible Health Plans and Bipolar Disorder

NCT02560701 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 350823

Last updated 2020-08-06

Study results available
· View outcomes & findings →

Summary

Using eleven years (2004-2014) of claims data from the largest US commercial health insurer, the investigators will assess the impact of switching into high-deductible health plans (HDHPs) on outcomes for patients with bipolar disorder. Patient subgroups will include patients with and without high medication cost-sharing and vulnerable populations (racial/ethnic minorities, poor, rural, major comorbidities). Interviews with patients and caregivers recruited through a major advocacy group will provide further insights into the policy issues with real-life experiences.

Conditions

Interventions

OTHER

Patient Interview

Investigators will conduct in-depth interviews with approximately 40 commercially insured individuals with bipolar disorder or their family caregivers to explore how they navigate deductibles, copayments, and other complex insurance features. Investigators will also determine the health care services that patients most value and assess how they prioritize difficult health care cost tradeoffs.

Sponsors & Collaborators

  • Depression and Bipolar Support Alliance

    collaborator UNKNOWN

  • NAMI: National Alliance on Mental Illness

    collaborator UNKNOWN

  • Harvard Pilgrim Health Care

    lead OTHER

Principal Investigators

  • James F Wharam, MD, MPH · Harvard Pilgrim Health Care Institute

Eligibility

Min Age
12 Years
Max Age
63 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2018-02-28
Completion
2018-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02560701 on ClinicalTrials.gov